• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,209.97
  • 0.74 %
  • $60.70
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Natera, Inc. (NTRA) Stock Price, News & Analysis

Natera, Inc. (NTRA) Stock Price, News & Analysis

Currency in USD Disclaimer

$169.27

$1.39

(0.83%)

Day's range
$164.4
Day's range
$171.95
50-day range
$117.27
Day's range
$171.95
  • Country: US
  • ISIN: US6323071042
52 wk range
$53.62
Day's range
$171.95
  • CEO: Mr. Steven Leonard Chapman
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 17.91
  • Piotroski Score 5.00
  • Grade Overweight
  • Symbol (NTRA)
  • Company Natera, Inc.
  • Price $169.27
  • Changes Percentage (0.83%)
  • Change $1.39
  • Day Low $164.40
  • Day High $171.95
  • Year High $171.95

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $129.00
  • High Stock Price Target $182.00
  • Low Stock Price Target $54.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$3.11
  • Trailing P/E Ratio -35.75
  • Forward P/E Ratio -35.75
  • P/E Growth -35.75
  • Net Income $-434,801,000

Income Statement

Quarterly

Annual

Latest News of NTRA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Natera, Inc. Frequently Asked Questions

  • What were the earnings of NTRA in the last quarter?

    In the last quarter Natera, Inc. earnings were on Tuesday, November, 12th. The Natera, Inc. maker reported -$0.26 EPS for the quarter, beating analysts' consensus estimates of -$0.57 by $0.31.

  • What is the Natera, Inc. stock price today?

    Today's price of Natera, Inc. is $169.27 — it has increased by +0.83% in the past 24 hours. Watch Natera, Inc. stock price performance more closely on the chart.

  • Does Natera, Inc. release reports?

    Yes, you can track Natera, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Natera, Inc. stock forecast?

    Watch the Natera, Inc. chart and read a more detailed Natera, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Natera, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Natera, Inc. stock ticker.

  • How to buy Natera, Inc. stocks?

    Like other stocks, NTRA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Natera, Inc.'s EBITDA?

    Natera, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Natera, Inc.’s financial statements.

  • What is the Natera, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.4016373984, which equates to approximately -40.16%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Natera, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Natera, Inc.'s financials relevant news, and technical analysis. Natera, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Natera, Inc. stock currently indicates a “sell” signal. For more insights, review Natera, Inc.’s technical analysis.

  • A revenue figure for Natera, Inc. for its last quarter?

    Natera, Inc. published it's last quarterly revenues at $439.76 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.